These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 28414135

  • 21. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
    Brewster ME, Vandecruys R, Peeters J, Neeskens P, Verreck G, Loftsson T.
    Eur J Pharm Sci; 2008 Jul 03; 34(2-3):94-103. PubMed ID: 18420390
    [Abstract] [Full Text] [Related]

  • 22. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
    Holvoet C, Vander Heyden Y, Plaizier-Vercammen J.
    Pharmazie; 2007 Jul 03; 62(7):510-4. PubMed ID: 17718191
    [Abstract] [Full Text] [Related]

  • 23. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T, Sandhu HK, Talele TT, Serajuddin AT.
    Pharm Res; 2016 Jun 03; 33(6):1456-71. PubMed ID: 26951566
    [Abstract] [Full Text] [Related]

  • 24. Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjects.
    Hens B, Masuy I, Deloose E, Mols R, Tack J, Augustijns P.
    Eur J Pharm Biopharm; 2020 May 03; 150():66-76. PubMed ID: 32113916
    [Abstract] [Full Text] [Related]

  • 25. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM, Beig A, Carr RA, Spence JK, Dahan A.
    Mol Pharm; 2012 Jul 02; 9(7):2009-16. PubMed ID: 22632106
    [Abstract] [Full Text] [Related]

  • 26. Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium.
    Van Den Abeele J, Brouwers J, Mattheus R, Tack J, Augustijns P.
    J Pharm Sci; 2016 Feb 02; 105(2):687-696. PubMed ID: 26375734
    [Abstract] [Full Text] [Related]

  • 27. Avoidance of food effect on oral absorption profile of itraconazole by self-micellizing solid dispersion approach.
    Kojo Y, Kobayashi K, Matsunaga S, Suzuki H, Seto Y, Sato H, Onoue S.
    Drug Metab Pharmacokinet; 2017 Oct 02; 32(5):273-276. PubMed ID: 28923421
    [Abstract] [Full Text] [Related]

  • 28. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM, Boyd B, Rades T, Müllertz A.
    Eur J Pharm Sci; 2016 Aug 25; 91():31-9. PubMed ID: 27260089
    [Abstract] [Full Text] [Related]

  • 29. Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.
    Wlodarski K, Zhang F, Liu T, Sawicki W, Kipping T.
    Pharm Res; 2018 Jan 05; 35(1):16. PubMed ID: 29305665
    [Abstract] [Full Text] [Related]

  • 30. Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid.
    Piao ZZ, Choe JS, Oh KT, Rhee YS, Lee BJ.
    Eur J Pharm Sci; 2014 Jan 23; 51():67-74. PubMed ID: 24012590
    [Abstract] [Full Text] [Related]

  • 31. The artificial membrane insert system as predictive tool for formulation performance evaluation.
    Berben P, Brouwers J, Augustijns P.
    Int J Pharm; 2018 Feb 15; 537(1-2):22-29. PubMed ID: 29241703
    [Abstract] [Full Text] [Related]

  • 32. Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid.
    Mellaerts R, Aerts A, Caremans TP, Vermant J, Van den Mooter G, Martens JA, Augustijns P.
    Mol Pharm; 2010 Jun 07; 7(3):905-13. PubMed ID: 20232903
    [Abstract] [Full Text] [Related]

  • 33. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M, Przyklenk KH, Richtberg A, Baumann W, Dressman JB.
    Eur J Pharm Biopharm; 2014 Nov 07; 88(3):795-806. PubMed ID: 25195981
    [Abstract] [Full Text] [Related]

  • 34. Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations.
    Tanaka Y, Tay E, Nguyen TH, Porter CJH.
    Pharm Res; 2020 Feb 03; 37(3):47. PubMed ID: 32016597
    [Abstract] [Full Text] [Related]

  • 35. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
    Lang B, Liu S, McGinity JW, Williams RO.
    Drug Dev Ind Pharm; 2016 Feb 03; 42(3):429-45. PubMed ID: 26355819
    [Abstract] [Full Text] [Related]

  • 36. Ethanol concentrations in the human gastrointestinal tract after intake of alcoholic beverages.
    Rubbens J, Brouwers J, Wolfs K, Adams E, Tack J, Augustijns P.
    Eur J Pharm Sci; 2016 Apr 30; 86():91-5. PubMed ID: 26898927
    [Abstract] [Full Text] [Related]

  • 37. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers.
    Woo JS, Song YK, Hong JY, Lim SJ, Kim CK.
    Eur J Pharm Sci; 2008 Feb 05; 33(2):159-65. PubMed ID: 18178070
    [Abstract] [Full Text] [Related]

  • 38. In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution.
    Yang W, Chow KT, Lang B, Wiederhold NP, Johnston KP, Williams RO.
    Eur J Pharm Sci; 2010 Mar 18; 39(5):336-47. PubMed ID: 20093186
    [Abstract] [Full Text] [Related]

  • 39. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
    Thiry J, Broze G, Pestieau A, Tatton AS, Baumans F, Damblon C, Krier F, Evrard B.
    Eur J Pharm Sci; 2016 Mar 31; 85():94-105. PubMed ID: 26850682
    [Abstract] [Full Text] [Related]

  • 40. The Effect of Food on the Intraluminal Behavior of Abiraterone Acetate in Man.
    Geboers S, Stappaerts J, Mols R, Snoeys J, Tack J, Annaert P, Augustijns P.
    J Pharm Sci; 2016 Sep 31; 105(9):2974-2981. PubMed ID: 27061460
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.